Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 10 studies | 29% ± 10% | |
intestine | 7 studies | 23% ± 9% | |
peripheral blood | 6 studies | 28% ± 8% | |
brain | 6 studies | 33% ± 11% | |
liver | 6 studies | 35% ± 22% | |
eye | 5 studies | 24% ± 8% | |
pancreas | 4 studies | 28% ± 8% | |
kidney | 4 studies | 20% ± 4% | |
uterus | 4 studies | 31% ± 13% | |
placenta | 3 studies | 27% ± 4% | |
breast | 3 studies | 32% ± 8% | |
prostate | 3 studies | 24% ± 5% | |
bone marrow | 3 studies | 18% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3446.98 | 1445 / 1445 | 100% | 88.93 | 183 / 183 |
ovary | 100% | 2139.83 | 180 / 180 | 100% | 52.70 | 430 / 430 |
pancreas | 100% | 3687.07 | 328 / 328 | 100% | 61.25 | 178 / 178 |
uterus | 100% | 2368.34 | 170 / 170 | 100% | 81.09 | 459 / 459 |
brain | 100% | 2900.53 | 2641 / 2642 | 100% | 87.89 | 705 / 705 |
breast | 100% | 3145.83 | 459 / 459 | 100% | 91.15 | 1117 / 1118 |
bladder | 100% | 3309.00 | 21 / 21 | 100% | 69.88 | 503 / 504 |
prostate | 100% | 2656.89 | 245 / 245 | 100% | 74.59 | 501 / 502 |
liver | 100% | 2542.01 | 226 / 226 | 100% | 47.74 | 405 / 406 |
lung | 100% | 2664.80 | 576 / 578 | 100% | 75.54 | 1155 / 1155 |
stomach | 100% | 2755.96 | 359 / 359 | 100% | 77.75 | 285 / 286 |
intestine | 100% | 2993.27 | 966 / 966 | 100% | 85.29 | 525 / 527 |
thymus | 100% | 2514.08 | 653 / 653 | 99% | 55.00 | 601 / 605 |
kidney | 100% | 2744.37 | 89 / 89 | 98% | 50.02 | 884 / 901 |
skin | 100% | 3498.93 | 1809 / 1809 | 96% | 67.96 | 455 / 472 |
adrenal gland | 100% | 3061.15 | 258 / 258 | 95% | 52.26 | 218 / 230 |
adipose | 100% | 3457.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3139.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 70.55 | 29 / 29 |
muscle | 100% | 8287.23 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2208.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 75.65 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.19 | 1 / 1 |
heart | 97% | 2484.63 | 831 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 37.14 | 72 / 80 |
peripheral blood | 70% | 1767.25 | 651 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001732 | Biological process | formation of cytoplasmic translation initiation complex |
GO_0006413 | Biological process | translational initiation |
GO_0033290 | Cellular component | eukaryotic 48S preinitiation complex |
GO_0005829 | Cellular component | cytosol |
GO_0016282 | Cellular component | eukaryotic 43S preinitiation complex |
GO_0005852 | Cellular component | eukaryotic translation initiation factor 3 complex |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | EIF3J |
Protein name | Eukaryotic translation initiation factor 3 subunit J Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35) |
Synonyms | EIF3S1 PRO0391 |
Description | FUNCTION: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis . The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation. The eIF-3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression . . |
Accessions | ENST00000535391.5 [O75822-2] H0YLP3 ENST00000536248.1 ENST00000261868.10 [O75822-1] O75822 ENST00000558353.1 H0YGJ7 ENST00000424492.7 [O75822-3] |